IRIDEX Corporation IRIX
0.65 USD -0.05 (-6.73%)
At closeNov 11, 2026, 5:25 PM EST
0.70 +0.05 +7.18%
After hours · Nov 11, 5:25 PM ET
0.653 Day range 0.7279
0.61 52-week range 1.56
- YTD
- -42.71%
- 1 year
- -45.12%
News
globenewswire.com Iridex to Report Third Quarter 2026 Financial Results on November 17, 2026 SAN JOSE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader in innovative laser-based medical systems, delivery devices, and accessories for the…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers SciSparc (NASDAQ:SPRC) shares moved upwards by 39.4% to $1.52 during Monday's pre-market session. Xencor (NASDAQ:XNCR) stock moved upwards by 29.46% to $32.6. The company's market cap stands…
benzinga.com Iridex Announces Publication Of 2-Yr Clinical Study Demonstrating Favorable Outcomes With TLT Using MicroPulse Technology In Patients With Primary Glaucoma Iridex Corporation (NASDAQ:IRIX), a worldwide leader in innovative laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced…
defenseworld.net IRIDEX (NASDAQ:IRIX) Stock: Insider Shih-Yao David Lin Acquires 10,000 Shares IRIDEX Corporation (NASDAQ: IRIX - Get Free Report) major shareholder Shih-Yao David Lin purchased 10,000 shares of IRIDEX stock in a transaction dated Thursday, October 16th. The shares were…
globenewswire.com Iridex Completes Relocation of Manufacturing Facility to San Jose, California Company Expects to Realize Approximately $600,000 in Annualized Cost Savings Company Expects to Realize Approximately $600,000 in Annualized Cost Savings
defenseworld.net IRIDEX (NASDAQ:IRIX) Shares Cross Below 200-Day Moving Average – Here’s Why IRIDEX Corporation (NASDAQ: IRIX - Get Free Report) crossed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $0.98 and traded as…
zacks.com IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15% IRIX's Q2 loss per share widens year over year and revenues decline as Middle East disruptions and reduced sell-through in China weigh on retina sales, offsetting continued growth in the Cyclo G6…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers ZeroStack (NASDAQ:ZSTK) stock increased by 440.2% to $9.94 during Wednesday's regular session. The company's market cap stands at $4.4 million. Tenon Medical (NASDAQ:TNON) shares moved…
seekingalpha.com IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript
benzinga.com Full Transcript: Iridex Q2 2026 Earnings Call Iridex (NASDAQ:IRIX) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts…
benzinga.com Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.
benzinga.com Iridex Q2 EPS $(0.07) Misses $(0.01) Estimate, Sales $12.566M Miss $13.587M Estimate Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.01) by 600 percent. This is a 16.67 percent decrease over losses of $(0.06) per…
globenewswire.com Iridex Reports Second Quarter 2026 Financial Results MOUNTAIN VIEW, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's after-market session. The market value of their outstanding shares is at $38.5 million. As per the press…
globenewswire.com Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026 MOUNTAIN VIEW, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…- benzinga.com Iridex Expands Its EyeProGPO Product Offering To Include The Company’s Line Of EndoProbe Handpieces Through the agreement, more than 4,300 EyeProGPO members will have access to preferred pricing on Iridex EndoProbe Handpieces, expanding the value Iridex provides to ophthalmology practices,…
globenewswire.com Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering MOUNTAIN VIEW, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…
globenewswire.com Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference MOUNTAIN VIEW, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…
zacks.com IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth IRIDEX posts a narrower year-over-year net loss per share in Q1'26 as strong glaucoma product sales and lower operating costs helped offset weakness in retina sales and supply-chain disruptions.
seekingalpha.com IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript- benzinga.com Iridex Q1 2026 Earnings Call: Complete Transcript
benzinga.com Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.- benzinga.com Iridex Q1 EPS $(0.03) Beats $(0.07) Estimate, Sales $11.799M Miss $11.910M Estimate Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 70 percent increase over losses of $(0.10) per…
globenewswire.com Iridex Reports First Quarter 2026 Financial Results MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…
benzinga.com Earnings Scheduled For May 19, 2026 
globenewswire.com Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 MOUNTAIN VIEW, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
globenewswire.com Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology MOUNTAIN VIEW, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…
zacks.com Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth IRIX incurs narrower year-over-year loss per share in Q4 as growth in retina systems and glaucoma probes boosts revenues, though margins remain pressured by higher costs.- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
seekingalpha.com IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript
benzinga.com Iridex Q4 EPS $(0.01) Beats $(0.02) Estimate, Sales $14.724M Miss $14.740M Estimate. Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 80 percent increase over losses of $(0.05) per share…
globenewswire.com Iridex Reports Fourth Quarter and Full Year 2025 Financial Results Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies- benzinga.com Earnings Scheduled For March 26, 2026
defenseworld.net IRIDEX (IRIX) Projected to Post Earnings on Thursday IRIDEX (NASDAQ: IRIX - Get Free Report) is expected to issue its Q4 2025 results before the market opens on Thursday, March 26th. Analysts expect the company to announce earnings of ($0.02) per share…
globenewswire.com Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026 MOUNTAIN VIEW, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Iridex Reports Preliminary Q4 2025 Revenue Of $14.6M–$14.8M, Up 15%–17% YoY, And Full-Year Revenue Of $52.5M–$52.7M, Up 8% YoY, While Achieving Positive Cash Flow And Adjusted EBITDA Fourth Quarter 2025 ResultsTotal revenue is expected to be between $14.6 million and $14.8 million compared to $12.7 million in the prior year quarter, representing year-over-year growth between 15%…- benzinga.com New Study Shows Iridex Laser Treatment Safely Lowers Eye Pressure for Glaucoma Patients Iridex Corporation (NASDAQ:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket 
benzinga.com Iridex Q3 EPS $(0.09) Up From $(0.12) YoY, Sales $12.484M Up From $11.581M YoY Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.09) per share. This is a 25 percent increase over losses of $(0.12) per share from the same period last year. The company reported $12.484…
benzinga.com Earnings Scheduled For November 11, 2025 - benzinga.com CORRECTION: Iridex Q2 EPS $(0.06) Misses $0.06 Estimate, Sales $13.57M Up From $12.63M YoY Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.06 by 200 percent. This is a 62.5 percent increase over losses of $(0.16) per…
benzinga.com Earnings Scheduled For August 12, 2025 - benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - benzinga.com Iridex Q1 GAAP EPS $(0.10) Up From $(0.21) YoY, Sales $11.90M Up From $11.76M YoY Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.10) per share. This is a 52.38 percent increase over losses of $(0.21) per share from the same period last year. The company reported $11.90…